BenevolentAI
Platform for AI-driven drug discovery in clinical-stage development.
3
Funding Rounds
$115.0m
Money raised
Overview
Platform for AI-driven drug discovery in clinical-stage development.
-
Website:
- Business model: B2B
- Social accounts:
Industries
BenevolentAI is active in the following industries: